| Marion Powell, MD | |
|
4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433-5529 | |
| (937) 522-2841 | |
| Not Available |
| Full Name | Marion Powell |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 4881 Sugar Maple Dr, Wright Patterson Afb, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659525558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 0101245973 (Virginia) | Secondary |
| 207W00000X | Ophthalmology | 0101245973 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marion Powell, MD 1100 Wilford Hall Loop Bldg 4554, San Antonio, TX 78236-5638 Ph: () - | Marion Powell, MD 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433-5529 Ph: (937) 522-2841 |
News Archive
Ampio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, whose lead drugs treat inflammatory diseases, including osteoarthritis and complications of Diabetes Mellitus such as diabetic macular edema (and others) announced today that it's CRO has completed analysis of the primary end point in the Optina clinical trial for DME conducted at St Michael Diabetes Hospital in Toronto Canada.
A new study published in the American Journal of Lifestyle Medicine finds critical links between job loss and physical inactivity in young adults during the U.S. Great Recession of 2008-09 that can be crucial to understanding the role of adverse economic shocks on physical activity during the COVID-19 pandemic.
Genome researchers from Bielefeld University's Center for Biotechnology (CeBiTec) headed by Professor Dr. Alfred P-hler have succeeded in sequencing the genome of the Chinese hamster. The Chinese hamster supplies the cell cultures used by the pharmaceutical industry to produce biopharmaceutical products such as antibodies used in medicine.
Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy for metastatic cervical cancer suggest potential new treatment options for a disease that currently has limited effective options and disproportionately impacts younger women.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced top-line results from two Phase 2 clinical studies of Z160 in chronic pain indications.
› Verified 4 days ago
Dr. John Francis Gillis Ii, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 88 Mdg/sghj 4881 Sugar Maple Dr, Bldg 830, Wright Patterson Afb, OH 45433 Phone: 937-522-2841 | |
Dr. Michael F Parsons, M.D Ophthalmology Medicare: Medicare Enrolled Practice Location: 4881 Sugar Maple Dr, Wright Patterson Afb, OH 45433 Phone: 937-257-3509 |